Papers publicated in recent years

1. Li Y, Liu B and Liang C. Letter by Li et al Regarding Article, Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling. Circulation. 2017; 136: 2092-2093.

2. Li Y, Zhou J, Song YH, Yu XY. Dominant and recessive imprinting of exosomes from parent cells. Nature Reviews Cardiology, 2017, 14(8): 491.

3.Li Y, Han C, Wang J, Zhou J, Liang C, Ranganna K and Song YH. Exosomes Mediate the Beneficial Effects of Exercise. Adv Exp Med Biol. 2017; 1000: 333-353.

4.Song YH, Shao L, Zhang Y, Zhou J, Liu B, Pan X, Geng YJ, Yu XY and Li Y. Exosomes Derived from Embryonic Stem Cells as Potential Treatment for Cardiovascular Diseases. Adv Exp Med Biol. 2017; 998: 187-206.

5.Shao L, Zhang Y, Lan B, Wang J, Zhang Z, Zhang L, Xiao P, Meng Q, Geng YJ, Yu XY and Li Y. MiRNA-Sequence Indicates That Mesenchymal Stem Cells and Exosomes Have Similar Mechanism to Enhance Cardiac Repair. Biomed Res Int. 2017; 2017: 4150705.

6.Shen C, Zhou J, Wang X, Yu XY, Liang C, Liu B, Pan X, Zhao Q, Song JL, Wang J, Bao M, Wu C, Li Y and Song YH. Angiotensin-II-induced Muscle Wasting is Mediated by 25-Hydroxycholesterol via GSK3beta Signaling Pathway. EBioMedicine. 2017; 16: 238-250.

7.Li Y, Song YH, Liu B and Yu XY. The potential application and challenge of powerful CRISPR/Cas9 system in cardiovascular research. Int J Cardiol. 2017; 227: 191-193.

8.Li Y, Song YH and Yu XY. Letter by Li et al Regarding Article, MiR-125b Is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis. Circulation. 2016; 133: e713.

9.Zhou J, Liu B, Liang C, Li Y and Song YH. Cytokine Signaling in Skeletal Muscle Wasting. Trends Endocrinol Metab. 2016; 27: 335-347.

10.Li Y, Shen Z and Yu XY. Transport of microRNAs via exosomes. Nat Rev Cardiol. 2015; 12: 198.

Patent application

1. Preparation of allogeneic mesenchymal stem cells edited by CRISPR and optimized by IGF and the application in the treatment of myocardial infarction. Inventor: Yangxin Li; Zhenya Shen; Lianbo Shao. Application number: CN105985985A.

2. New use of exosomes secreted by mesenchymal stem cells for the treatment of myocardial infarction. Inventor: Yangxin Li. Application number: CN105395571A.

3. Polypeptide, recombinant DNA molecule, recombinant vector, exosomes and their applications. Inventors:  Yangxin Li;  Chaoshan Han ; Zhenya Shen. Application number: CN108623657A.

4. Polypeptide nanofiber hydrogel for sustained release exosomes and preparation method and application thereof. Inventor: Yangxin Li ;  Chaoshan Han. Application number: CN108853147A.

Fund support

1. General program of the National Natural Science Foundation of China

2. Training Program of the Major Research Plan of the National Natural Science Foundation of China

3. Jiangsu Province “six talent peaks” innovation team

4. Innovation and entrepreneurial team in Jiangsu Province

5. Jiangsu Province Key Research and Development Program (Social Development)

6. Suzhou citizen life science and technology project

7. High-level talents in Suzhou universities and research institutes

8. Innovation and entrepreneurial talent in Jiangsu Province

9. Start-up expenses in Soochow University